Free 30-minute strategy call — schedule a time or tell us about your company
MEDTECH COMMERCIALIZATION PARTNERS

Beyond Strategy.
Into Execution.

We build the commercial foundation that transforms breakthrough medical technologies into clinically adopted, market-leading healthcare companies — accelerating physician adoption, investor confidence, and patient impact.

Seed → Series DGrowth-stage MedTech partners
20+ YearsGlobal commercialization leadership
4,000+ PhysiciansEducated through KOL programs
Our Purpose

ARLE Catalyst builds the commercial foundation that transforms breakthrough medical technologies into clinically adopted, market-leading healthcare companies — accelerating physician adoption, investor confidence, and patient impact.

20+Years in global MedTech leadership
50+Countries of market expansion experience

"We build the commercial foundation that transforms breakthrough medical technologies into clinically adopted, market-leading healthcare companies — accelerating physician adoption, investor confidence, and patient impact."

Why One Partner

Most growth-stage MedTech companies are managing five vendors instead of one strategy.

Without one partner

Marketing Agency
PR Agency
Website Agency
Conference Agency
Clinical Marketing Consultant
The ResultChaos · Broken communication · Different priorities · Multiple invoices · No single owner

With ARLE Catalyst

  1. Commercialization Strategy
  2. Clinical Research Strategy — Clinic Onboarding & Patient Enrollment
  3. Vendor & Partner Selection — Pre-Vetted for Quality Outcomes
  4. Cross-Functional Leadership
  5. Execution Management
  6. Executive Scorecards & Board Reporting
CEOOne partner
CFOOne budget
ClinicalOne roadmap
Our Commercialization Model & Roadmap

Three phases. One embedded team, from concept to commercial scale.

This is the detailed view of what happens behind the scenes to prepare for commercialization — whether the path is going to market or being acquired. These are the building blocks required to implement effectively and efficiently, and to act as a true catalyst for growth.

01  Build

Concept → First-in-Human
Discovery
Concept
Prototype
Preclinical
What We Build Commercially
The commercial foundation required before market entry.
  • EOS value assessment & gap identification
  • Clinical strategy
  • Regulatory alignment
  • Commercial strategy & roadmap
  • Competitive assessment
  • Messaging & brand identity
  • Investor relations strategy & positioning
  • Digital strategy — by audience
  • Physician & patient customer journey mapping
  • KOL strategy — engagement, advising, coaching
  • Competitive analysis

02  Launch

First-in-Human → FDA Submission
First-in-Human
Feasibility
Pivotal Trial
FDA Submission
What We Build Commercially
Sustaining clinical & market momentum through milestone execution.
  • Clinical marketing & site engagement
  • Scientific communications
  • Medical education
  • Conferences & symposia
  • Investor communications
  • Campaign optimization
  • Market analytics to scale phase
  • Manufacturing demand forecasting
  • Digital social listening

03  Scale

FDA Submission → Launch → Expansion
FDA Clearance
Commercial Launch
Market Expansion
What We Build Commercially
Preparing the organization for rapid commercial adoption at scale.
  • Commercialization & launch execution
  • Market access & VAC toolkits
  • Physician adoption
  • Sales enablement
  • Global expansion
Successful launches begin 18–24 months before FDA submission.
How We Work

Every touchpoint builds physician confidence, investor awareness, and commercial readiness.

This is the ecosystem of commercial assets built throughout the journey — typically an 18–36 month engagement from early Build work through full Scale.

01

Digital Ecosystem

Corporate website, clinical trial microsite, investor landing page, site recruitment portal, email & LinkedIn campaigns, SEO.

02

Scientific Communications

Press releases, clinical data summaries, scientific posters, investigator brochures, physician leave-behinds, publication graphics.

03

Physician Experience

End-to-end journey design from first touch through site activation — toolkits, procedure animation, referral & training materials.

04

Clinical Research & Site Strategy

Clinic onboarding and patient enrollment strategy, backed by a pre-vetted network of agency partners for quality outcomes — or we evaluate new vendors together.

05

Conference & Market Presence

Booth strategy, hosted executive meetings, KOL roundtables, investor dinners — converting presence into pipeline.

06

Investor Experience

Investor decks, financial infographics, milestone timelines, data room readiness, board reporting cadence.

07

Patient & Market Access

Patient education journeys, VAC toolkits, reimbursement narrative, referral pathway mapping.

Prefer to work project-by-project?

Not every company needs the full 18–36 month journey right away. We also scope focused, standalone projects — here are a few common starting points.

Commercialization Readiness Assessment Conference & Launch Sprint Investor Narrative & Deck KOL Program Build Digital & Brand Refresh Market Access Strategy Clinical Site & Enrollment Plan
Ideal Fit

Built for MedTech companies at critical growth milestones.

Seed through Series D financing
FDA pathways (510(k), De Novo, PMA, IDE)
Clinical development & evidence generation
Commercial launch preparation
New indication & portfolio expansion
Strategic acquisitions
U.S. commercialization
Global expansion & international entry
Corporations & enterprise teams launching new product lines
Learn More

Meet Andrea, and get answers to the questions founders ask most.

Start the Conversation

Tell us about your company.

A few details help us prepare for a focused first conversation — no commitment, no pricing pressure.

We reply within 1–2 business days. No pricing is shared until we understand your needs.

Thank you — message received.

Andrea will follow up within 1–2 business days. In the meantime, feel free to schedule a call directly below.

Something went wrong sending this.

Please email your details directly to andrea@arlecatalyst.com instead — we'll get back to you within 1–2 business days.

Prefer to talk it through directly? Book a free 30-minute strategy call — pick a time that works for you.

Schedule a Meeting →
Partnership Inquiries

Let's build the commercial foundation behind your breakthrough.

Whether you're preparing for FDA submission or scaling toward Series D, we embed as your commercial team — not another vendor.